日本膜性肾病患者幽门螺杆菌感染高发

T. MORIYAMA, T. KANEKO, M. FUJII, Y. TSUBAKIHARA, S. KAWANO, E. IMAI
{"title":"日本膜性肾病患者幽门螺杆菌感染高发","authors":"T. MORIYAMA,&nbsp;T. KANEKO,&nbsp;M. FUJII,&nbsp;Y. TSUBAKIHARA,&nbsp;S. KAWANO,&nbsp;E. IMAI","doi":"10.1111/j.1746-6342.2006.00044.x","DOIUrl":null,"url":null,"abstract":"<div>\n \n <section>\n \n <h3> Summary</h3>\n </section>\n \n <section>\n \n <h3> Background</h3>\n \n <p>Membranous nephropathy is the most common cause of nephrotic syndrome in Japanese adults, and is often precipitated by systemic diseases such as infection, neoplasm, and autoimmune conditions. Recently, the <i>Helicobacter pylori</i> antigen was detected histochemically in the glomeruli of membranous nephropathy patients, raising the possibility that <i>H. pylori</i> may be the pathogen that causes.</p>\n </section>\n \n <section>\n \n <h3> Aim</h3>\n \n <p>To reveal the p1revalence of <i>H. pylori</i> infection in the Japanese membranous nephropathy population and to test the therapeutic efficacy of <i>H. pylori</i> eradication on the course of disease in membranous nephropathy patients.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>The prevalence of <i>H. pylori</i> infection was investigated by the HM-CAP method in 32 membranous nephropathy patients and an age-matched control group (C: <i>n</i> = 243).</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>A significantly higher <i>H. pylori</i> infection rate was found in membranous nephropathy patients than in the control group (positive/total: membranous nephropathy 21/32 vs. C 108/243, <i>P</i> &lt; 0.05 by chi-squared test). Eradication of <i>H. pylori</i> was achieved in four membranous nephropathy patients with proteinuria who were receiving glucocorticoid therapy, three of whom experienced a reduction of proteinuria after eradication.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>We found a higher prevalence of <i>H. pylori</i> infection in Japanese membranous nephropathy patients than in age-matched control subjects, which suggests the possible involvement of <i>H. pylori</i> infection in the pathogenesis of membranous nephropathy.</p>\n </section>\n </div>","PeriodicalId":50822,"journal":{"name":"Alimentary Pharmacology & Therapeutics Symposium Series","volume":"2 1","pages":"189-193"},"PeriodicalIF":0.0000,"publicationDate":"2006-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1746-6342.2006.00044.x","citationCount":"0","resultStr":"{\"title\":\"High prevalence of Helicobacter pylori infection in Japanese patients with membranous nephropathy\",\"authors\":\"T. MORIYAMA,&nbsp;T. KANEKO,&nbsp;M. FUJII,&nbsp;Y. TSUBAKIHARA,&nbsp;S. KAWANO,&nbsp;E. IMAI\",\"doi\":\"10.1111/j.1746-6342.2006.00044.x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n <section>\\n \\n <h3> Summary</h3>\\n </section>\\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Membranous nephropathy is the most common cause of nephrotic syndrome in Japanese adults, and is often precipitated by systemic diseases such as infection, neoplasm, and autoimmune conditions. Recently, the <i>Helicobacter pylori</i> antigen was detected histochemically in the glomeruli of membranous nephropathy patients, raising the possibility that <i>H. pylori</i> may be the pathogen that causes.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Aim</h3>\\n \\n <p>To reveal the p1revalence of <i>H. pylori</i> infection in the Japanese membranous nephropathy population and to test the therapeutic efficacy of <i>H. pylori</i> eradication on the course of disease in membranous nephropathy patients.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>The prevalence of <i>H. pylori</i> infection was investigated by the HM-CAP method in 32 membranous nephropathy patients and an age-matched control group (C: <i>n</i> = 243).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>A significantly higher <i>H. pylori</i> infection rate was found in membranous nephropathy patients than in the control group (positive/total: membranous nephropathy 21/32 vs. C 108/243, <i>P</i> &lt; 0.05 by chi-squared test). Eradication of <i>H. pylori</i> was achieved in four membranous nephropathy patients with proteinuria who were receiving glucocorticoid therapy, three of whom experienced a reduction of proteinuria after eradication.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>We found a higher prevalence of <i>H. pylori</i> infection in Japanese membranous nephropathy patients than in age-matched control subjects, which suggests the possible involvement of <i>H. pylori</i> infection in the pathogenesis of membranous nephropathy.</p>\\n </section>\\n </div>\",\"PeriodicalId\":50822,\"journal\":{\"name\":\"Alimentary Pharmacology & Therapeutics Symposium Series\",\"volume\":\"2 1\",\"pages\":\"189-193\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2006-06-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1111/j.1746-6342.2006.00044.x\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alimentary Pharmacology & Therapeutics Symposium Series\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/j.1746-6342.2006.00044.x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alimentary Pharmacology & Therapeutics Symposium Series","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/j.1746-6342.2006.00044.x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

膜性肾病是日本成人肾病综合征最常见的病因,通常由感染、肿瘤和自身免疫性疾病等全身性疾病引起。最近,在膜性肾病患者的肾小球中组织化学检测到幽门螺杆菌抗原,提高了幽门螺杆菌可能是致病病原体的可能性。目的了解幽门螺杆菌在日本膜性肾病人群中的感染情况,探讨根除幽门螺杆菌对膜性肾病患者病程的治疗效果。方法采用HM-CAP法对32例膜性肾病患者和年龄相匹配的对照组(243例)进行幽门螺杆菌感染调查。结果膜性肾病患者幽门螺杆菌感染率明显高于对照组(阳性/总:膜性肾病患者21/32比C 108/243, χ 2检验P < 0.05)。在4例接受糖皮质激素治疗的伴有蛋白尿的膜性肾病患者中实现了幽门螺杆菌的根除,其中3例患者在根除后蛋白尿减少。结论日本膜性肾病患者幽门螺杆菌感染率高于同龄对照组,提示幽门螺杆菌感染可能参与了膜性肾病的发病机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
High prevalence of Helicobacter pylori infection in Japanese patients with membranous nephropathy

Summary

Background

Membranous nephropathy is the most common cause of nephrotic syndrome in Japanese adults, and is often precipitated by systemic diseases such as infection, neoplasm, and autoimmune conditions. Recently, the Helicobacter pylori antigen was detected histochemically in the glomeruli of membranous nephropathy patients, raising the possibility that H. pylori may be the pathogen that causes.

Aim

To reveal the p1revalence of H. pylori infection in the Japanese membranous nephropathy population and to test the therapeutic efficacy of H. pylori eradication on the course of disease in membranous nephropathy patients.

Methods

The prevalence of H. pylori infection was investigated by the HM-CAP method in 32 membranous nephropathy patients and an age-matched control group (C: n = 243).

Results

A significantly higher H. pylori infection rate was found in membranous nephropathy patients than in the control group (positive/total: membranous nephropathy 21/32 vs. C 108/243, P < 0.05 by chi-squared test). Eradication of H. pylori was achieved in four membranous nephropathy patients with proteinuria who were receiving glucocorticoid therapy, three of whom experienced a reduction of proteinuria after eradication.

Conclusions

We found a higher prevalence of H. pylori infection in Japanese membranous nephropathy patients than in age-matched control subjects, which suggests the possible involvement of H. pylori infection in the pathogenesis of membranous nephropathy.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Review article: exploring strategies to improve treatment outcomes and compliance in specific patient groups with acid–related disorders Review article: issues in acid-related disorders in children in Asian countries Review article: management issues in acid-related disorders in the elderly Review article: building an algorithm for the management of geriatric acid-related disorders in Asia Clinical practice recommendations for acid-related disorders or GERD from childhood to old age in Asia: summary of workshop report
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1